Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Ika, Kardum"'
Autor:
Josipa Skelin, Maja Matulić, Lidija Milković, Darko Heckel, Jelena Skoko, Kristina Ana Škreb, Biljana Jelić Puškarić, Ika Kardum-Skelin, Lipa Čičin-Šain, Delfa Radić-Krišto, Mariastefania Antica
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 524 (2024)
Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder characterized by a specific expansion of mature B-cell clones. We hypothesized that the disease has a heterogeneous clinical outcome that depends on the genes and signaling pathways
Externí odkaz:
https://doaj.org/article/bb85a3313e2b4e2a8da98e1fdc05d944
Autor:
Luka Horvat, Josipa Skelin, Biljana Jelić Puškarić, Isidoro Feliciello, Darko Heckel, Josip Madunić, Ika Kardum-Skelin, Maja Matulić, Delfa Radić-Krišto, Mariastefania Antica
Publikováno v:
Translational Medicine Communications, Vol 3, Iss 1, Pp 1-9 (2018)
Abstract Background The Notch pathway combined with other signalling molecules acts specifically for the development of each blood cell type and differentiation stage. A causative role of Notch dysfunction in leukaemia development has been found in m
Externí odkaz:
https://doaj.org/article/504e88bf4ee342458df3787e423f01a0
Autor:
Branimir Jakšić, Vlatko Pejša, Slobodanka Ostojić-Kolonić, Ika Kardum-Skelin, Sandra Bašić-Kinda, Božena Coha, Velka Gverić-Krečak, Radovan Vrhovac, Ozren Jakšić, Igor Aurer, Jasminka Sinčić-Petričević, Antica Načinović-Duletić, Damir Nemet
Publikováno v:
Acta Clinica Croatica, Vol 57., Iss 1., Pp 190-215 (2018)
Recent developments in the diagnosis and treatment of chronic lymphocytic leukemia (B-CLL) have led to change of approach in clinical practice. New treatments have been approved based on the results of randomized multicenter trials for first line and
Externí odkaz:
https://doaj.org/article/3456c52f7ecf4f5f94305aa0fcdf4b6f
Autor:
Ljubica Fustar Preradovic, Davorin Danic, Ika Kardum-Skelin, Bozena Sarcevic, Ana Danic Hadzibegovic
Publikováno v:
Southeastern European Medical Journal, Vol 1, Iss 2, Pp 19-26 (2017)
Objective. Minimally invasive surgery is the method of choice in the management of hyperparathyroidism caused by parathyroid adenoma, whereas in case of parathyroid hyperplasia radical operative procedure is necessary to prevent recurrence of the dis
Externí odkaz:
https://doaj.org/article/bad81b303bca492680872d3cc892c810
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 1, Pp 163-168 (2013)
The synchronous or metachronous coexistence of gastrointestinal stromal tumors (GISTs) with solid and hematologic neoplasms has been addressed in a non-transplant population. However, the association with primary hepatic neoplasms and leukemias is un
Externí odkaz:
https://doaj.org/article/f37b1c8e8ec04331b1c523c24c40e600
Autor:
Orjena Žaja, Marina Mataija, Barbara Perše, Matea Crnković Ćuk, Matej Katavić, Ika Kardum-Skelin
Publikováno v:
Abstracts.
Autor:
Anita Škrtić, Gordana Kaić, Mirjana Mariana Kardum Paro, nga Mandac Rogulj, Biljana Jelić Puškarić, Ika Kardum-Skelin, Slobodanka Ostojić Kolonić
Publikováno v:
Liječnički vjesnik. 141:226-232
Myelodisplasia or myelodysplastic syndrome (MDS) is the name for a group of heterogeneous clonal hematological disorders of hematopoietic stem cells followed by ineffective hematopoesis of one or more cell lines and the emergence of consequent cytope
Autor:
Slobodanka Ostojić Kolonić, Ika Kardum-Skelin, Suzana Katalenić Simon, Mia Šunjić Stakor, Delfa Radić Krišto, Inga Mandac Rogulj, Marina Pažur, Gordana Kaić, Biljana Jelić Puškarić
Publikováno v:
Liječnički vjesnik. 141:220-225
Diagnostic category of MDS/MPN includes clonal hematopoietic neoplasms, which show the concomitant clinical, laboratory and/or morphologic features of both myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN) at the time of diagnosis.
Autor:
Mia Šunjić Stakor, Ika Kardum-Skelin, Marko Martinović, Gordana Kaić, Biljana Jelić Puškarić, Slobodanka Ostojić Kolonić, Marina Pažur, Delfa Radić Krišto
Publikováno v:
Liječnički vjesnik. 141:209-213
Mijelodisplastični sindrom heterogena je grupa bolesti koje dijele neka klinička i morfološka obilježja. Uzrok im je nepoznat. Budući da brz razvoj molekularne genetike omogućuje uvid u uzročne genske aberacije, danas se mogu odrediti neki pat
Autor:
Inga Mandac Rogulj, Ika Kardum-Skelin, Njetocka Gredelj-Simec, Sanja Davidović Mrsić, Dražen Perica, Karla Mišura Jakobac, Anita Škrtić, Vibor Milunović, Slobodanka Ostojić Kolonić
Publikováno v:
Liječnički vjesnik. 141:238-246
Introduction: Myelodysplastic syndrome (MDS) is one of the most common myeloid neoplasms of elderly characterized by cytopenias and limited therapeutic options. The main aim of this retrospective single-center study was to examine the value of classi